- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Bevacizumab – March 2011
Bevacizumab, solution for I.V. infusion, 100 mg in 4 mL and 400 mg in 16 mL, Avastin® - March 2011
Last updated
5 July 2011